Blood Transfusion Diagnostics Marwas valued at USD 4.61 billion in 2023 and is expected to reach USD 7.73 billion by 2032, growing at a CAGR of 5.91% from 2024-2032.
The comprehensive analysis of the Blood Transfusion Diagnostics market includes market taxonomy and trends, key statistical insights, and the incidence and prevalence of blood disorders requiring transfusions in 2023. The report details prescription trends by region, device volume across regions, and healthcare spending by government, commercial, private, and out-of-pocket expenditures. Furthermore, it analyzes the increasing reliance on automated systems of diagnostics, the importance of updated blood screening technologies, and the rapidly growing demand for precision diagnostics in blood transfusions. It also discusses the trends in regulatory frameworks and their impact on diagnostic device adoption, providing a comprehensive view of the market growth.
Drivers
Rising Incidence of Blood Disorders and Hematological Diseases propelling the Blood Transfusion Diagnostics Market growth.
Blood-related disorders, such as anemia, thalassemia, hemophilia, and sickle cell disease, are all on the rise, and coupling that with the out-of-control blood boom around the globe is one of the most powerful inducers for the Blood Transfusion Diagnostics market. As per the data from the World Health Organization (WHO), almost 1.62 billion globally suffer from anemia, with high rates being reported in countries such as sub-Saharan Africa and South Asia. This increasing prevalence fuels the demand for effective and accurate diagnostics for blood screening and transfusion. The rising number of surgeries and trauma cases needing blood transfusion is also fueling the demand for diagnostic tools to ensure blood type compatibility and reduce transfusion reactions, thus boosting the global market.
Advancements in Blood Transfusion Diagnostic Technology accelerating the market growth
Technological advancements in diagnostics for blood transfusion, especially in blood screening and blood-typing systems, are driving the growth of the market. The emergence of next-generation innovative, AI-enabled diagnostic tools and high-throughput blood screening devices. The data for May 2024, for instance, Thermo Fisher Scientific launched the Applied Biosystems Axiom BloodGenomiX Array, which provides a high degree of accuracy in the detection of extended blood groups and rare blood groups that can help in the optimization of blood transfusion matching. These advancements help enhance the accuracy of blood transfusion diagnostics that minimize transfusion-related complications and, thereby, increase the demand for advanced systems at clinical as well as emergency sites.
Restraint
High Cost of Diagnostic Systems Restraining the Blood Transfusion Diagnostics Market Growth.
The high expenditure involved in advanced blood transfusion diagnostic systems is one of the major restraining factors that are expected to hinder the market during the forecast period, which in turn is anticipated to impede market growth, particularly in low- and middle-income regions. Investing heavily in infrastructure and training for the solutions of state-of-the-art technology, such as high-throughput blood screening and artificial intelligence diagnostic tools This may result in low adoption, particularly in resource-poor environments, where budgetary constraints once again limit access to such advanced solutions. Consequently, the cost factor limits their widespread applicability in several hospitals and clinical laboratories, which hampers their market growth in various regions. Moreover, these systems require continual upkeep and maintenance, which entails further costs that make them unreachable for healthcare facilities with rattled budgets.
Opportunities
The integration of artificial intelligence (AI) and automation in blood transfusion diagnostics presents a significant market opportunity.
Diagnosis AI can bring about unprecedented accuracy, speed, and efficiency in screening for infections and matching blood types. Automation can reduce the possibility of human error and lower labor costs, and it is attractive to healthcare providers looking to improve operational efficiency and patient outcomes. With healthcare systems across the globe moving towards the adoption of digital technologies to improve diagnostic procedures, the demand for AI-based solutions in blood transfusion diagnostics is forecasted to increase. This trend opens great growth opportunities for companies that are designing new-generation diagnostic tools and systems based on such innovative technologies.
Challenges
The blood transfusion diagnostics market faces significant challenges related to stringent regulatory requirements and compliance standards.
Stringent regulatory requirements and compliance standards are among the key obstacles hindering the growth of the blood-transfusion diagnostics market. Manufacturers can face challenges via disparate regulatory practices around the world, resulting in difficulties in achieving harmonized access to important markets for diagnostic products. New diagnostic technologies face numerous regulatory hurdles with extensive approval processes that can delay the launch of products or inhibit them altogether from entering the market. Further expansion of regulatory policies, especially in regions with intricate healthcare procedures, may pose challenges for compliance, further increasing the risk of product recall, payment of fines, or delay in market launch. The pile-up of multi-country regulations numbers and the overall complexity pose challenges to companies that intend to bring forth innovative solutions in the blood transfusion diagnostics landscape.
By Product
The Reagents & Kits segment dominated the market and accounted for the 65.23% market share in 2023 of the Blood Transfusion Diagnostics Market due to their critical role in ensuring accurate and reliable blood testing procedures. The reagents and kits are used for blood typing, infectious disease screening, and cross-matching, which are interdependent and important steps in the blood transfusion process. Their increasing demand is due to the ever-expanding need for effective and safe blood transfusion, especially in hospitals, blood banks, and diagnostic laboratories. Their ubiquity is also boosted by pre-packaged kits for use and standardized testing. Never-ending innovations in this segment, including better reagents for rare blood types and improved kits for quick results, are still maintaining the dominance of this segment in the market.
Ongoing improvements in output precision and test materials sensitivity are expected to be a key driver of growth of this segment, especially on account of rising patient safety and quality during blood transfusion processes. As the standards and regulations in blood testing increase, the demand for high-quality, reliable reagents and kits is also increasing rapidly, solidifying this segment's market leadership. With the increase in blood donation programs around the world, the demand for such diagnostic products will continue to rise, thereby propelling growth.
By Application
The Disease Screening segment dominated the market with 62.32% market share in 2023 the Blood Transfusion Diagnostics Market is also projected to register the fastest growth throughout the forecast period as an increasing emphasis is being put on screening blood for infectious diseases consisting of HIV, Hepatitis, and other infectious microorganisms. The widespread implementation of disease screening technologies has been mainly driven by a greater focus on blood safety. Moreover, the increasing global health initiatives to reduce the transmission of several infectious diseases via blood transfusion are also stimulating the significant demand for disease screening tools.
The blood screening instruments and analyzers segment is owing to the increasing awareness regarding blood safety, as well as the rising number of blood transfusions every year. Technology has also been developed to create new diagnostic tools, improve real-time screening tests, and use automated systems to enhance the efficiency and accuracy of disease screening, making it easier to integrate the latest tests into the blood transfusion process. Additionally, an increasing number of blood donors coupled with the growing incidence of chronic diseases are propelling the market's swift expansion.
By End-Use
The blood banks segment dominated the market with 40.25% of the market share in 2023. Blood banks are integral points for blood collection, storage, and testing, which needs high-accuracy diagnostic tools for detecting infectious diseases, blood types, and other essential facets. As awareness about blood safety, as well as stringent regulations, have increased, blood banks have become vital in ensuring that only safe blood is provided to the patients. This has propelled the demand for preventive diagnostic instruments, thereby establishing the segment's expertise in the market.
This segment is likely to witness the fastest growth during the forecast period owing to rising global demand for blood products, especially in emerging economies with growing healthcare infrastructure. The growing number of chronic diseases like cancer and anemia that require regular transfusion and the increasing frequency of trauma and surgical procedures also fuel the demand for blood banks. Moreover, the growth in this segment can also be attributed to advancements in blood screening technology and government initiatives for safe blood donation and transfusion.
North America dominated the market with 40.46% of the market share in 2023 due to advanced healthcare infrastructure, widely adopted innovative diagnostic technologies, and well-established healthcare policies in the region contributing to its market share. The rapid availability of advanced blood transfusion diagnostic tools is attributed to the presence of market leaders, including Thermo Fisher Scientific Illumina, among others. In addition, the high incidence of blood-related diseases, in conjunction with the widespread government and private sector investments in healthcare, also supports the growth of the blood transfusion diagnostics market. The North American regulatory framework further reinforces this, providing stringent quality controls for diagnostics, leading to faster approvals and greater market share.
The blood transfusion diagnostics market in Asia Pacific is predicted to grow the fastest at a CAGR of 8.62%, owing to the speedy development of healthcare infrastructure, growing medical tourism, and rising government expenditure on healthcare services. Countries such as China and India are making great strides in improving their healthcare systems and access to advanced diagnostics, including blood transfusion testing. Moreover, the increasing occurrence of blood disorders and the geriatric population in the regions further propel the demand for precise and efficient diagnostics. Owing to rising awareness and affordability of health care, especially with more cost-effective diagnostic solutions entering the market.
Key Players in the Blood Transfusion Diagnostics Market
Illumina, Inc. (Verifi Prenatal Test, TruSight NIPT Solution)
Thermo Fisher Scientific Inc. (Thermo Scientific Dako Blood Transfusion Kits, Thermo Scientific Invitrogen Immunoassays)
Abbott Laboratories (Alinity's System, PRISM HIV O Plus Assay)
Grifols (Procleix Panther System, Grifols Blood Typing Reagents)
Siemens Healthineers (ADVIA Centaur XP Immunoassay System, Atellica IM TSH)
Roche Diagnostics (Cobas e 411 Analyzer, Roche Diagnostics Blood Transfusion Kits)
Beckman Coulter, Inc. (Access 2 Immunoassay System, Coulter LH 750 Hematology Analyzer)
Becton Dickinson and Company (BD Max System, BD Vacutainer Blood Collection Tubes)
Ortho Clinical Diagnostics (Ortho Vision Analyzer, Ortho Workstation)
Bio-Rad Laboratories, Inc. (BioPlex 2200, Bio-Rad Transfusion Diagnostic Systems)
Akers Biosciences (The BreathScan Alcohol Breathalyzer, The Blood Typing Test)
MacoPharma (Macotest Blood Typing, MacoBlood IV-Drug Test)
F. Hoffmann-La Roche AG (Cobas 8000 Series, Roche Cobas Liat System)
Sysmex Corporation (Sysmex XN-Series, Sysmex XN-31 Hematology Analyzer)
Quidel Corporation (QuickVue Influenza A+B Test, QuickVue At-Home Test Kit)
Abcam (Human Blood Typing Reagents, Hemoglobin Subunit Antibodies)
BioMerieux (VIDAS Blood Culture System, BioFire FilmArray Blood Culture Panel)
Sekisui Diagnostics (Sapphire Blood Typing, Immunoassay Panels)
Diacor (Diacor Blood Typing Kits, Diacor Immunoassay Systems)
Wako Pure Chemical Industries, Ltd. (Human Blood Coagulation Reagents, Blood Typing Reagents)
Suppliers
Thermo Fisher Scientific Inc.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
Siemens Healthineers
Roche Diagnostics
Illumina, Inc.
Grifols
Abbott Laboratories
Ortho Clinical Diagnostics
Becton Dickinson and Company
December 10, 2024 – Siemens Healthineers announced that it has completed the acquired Advanced Accelerator Applications Molecular Imaging from Novartis. This Europe-based network specializes in diagnostic radiopharmaceuticals used in positron-emission tomography (PET) scans. The company will operate as Advanced Accelerator Applications, now as part of Siemens Healthineers, following the acquisition.
August 2024 -- Illumina, Inc., a global leader in DNA sequencing and array-based technologies, today announced that the U.S. Food and Drug Administration (FDA) has approved its TruSight Oncology (TSO) Comprehensive test as an in vitro diagnostic (IVD) device. This test analyzes over 500 genes from a solid tumor to profile a patient's tumor to maximize the likelihood of detecting an immuno-oncology biomarker (or other clinically actionable markers). This will enable affected individuals to benefit from targeted therapy options and participate in clinical trials for new drugs.
In May 2024 – Thermo Fisher Scientific Inc. released the Applied Biosystems Axiom BloodGenomiX Array and software. This unique array enables the detection of the entire range of complex extended and rare blood groups as well as tissue (HLA) and platelet (HPA) types in a single high-throughput assay. The novel technology may improve future innovation in donor blood matching, particularly extended phenotypes.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ US$ 4.61 Billion |
| Market Size by 2032 | US$ 7.73 Billion |
| CAGR | CAGR of 5.91% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Reagents & Kits, Instruments, Others) • By Application (Blood Grouping, Disease Screening) • By End-Use (Hospitals, Blood Banks, Diagnostics Laboratories, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Illumina, Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Grifols, Siemens Healthineers, Roche Diagnostics, Beckman Coulter, Inc., Becton Dickinson and Company, Ortho Clinical Diagnostics, Bio-Rad Laboratories, Inc., Akers Biosciences, MacoPharma, F. Hoffmann-La Roche AG, Sysmex Corporation, Quidel Corporation, Abcam, BioMerieux, Sekisui Diagnostics, Diacor, Wako Pure Chemical Industries, Ltd., and other players. |
Ans: The Blood Transfusion Diagnostics Market is expected to grow at a CAGR of 5.91% during 2024-2032.
Ans: The Blood Transfusion Diagnostics Market was USD 4.61 billion in 2023 and is expected to Reach USD 7.73 billion by 2032.
Ans: Rising Incidence of Blood Disorders and Hematological Diseases propelling the Blood Transfusion Diagnostics Market growth.
Ans: The “Reagents & kits” segment dominated the Blood Transfusion Diagnostics Market.
Ans: North America dominated the Blood Transfusion Diagnostics Market in 2023
Table of Content
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Blood Transfusion Diagnostics Market Segmentation, by Product
7.1 Chapter Overview
7.2 Reagents & kits
7.2.1 Reagents & kits Market Trends Analysis (2020-2032)
7.2.2 Reagents & kits Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Instruments
7.3.1 Instruments Market Trends Analysis (2020-2032)
7.3.2 Instruments Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Others
7.4.1 Others Market Trends Analysis (2020-2032)
7.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Blood Transfusion Diagnostics Market Segmentation, by Application
8.1 Chapter Overview
8.2 Blood grouping
8.2.1 Blood Grouping Market Trends Analysis (2020-2032)
8.2.2 Blood Grouping Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Disease screening
8.3.1 Disease Screening Market Trends Analysis (2020-2032)
8.3.2 Disease Screening Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Blood Transfusion Diagnostics Market Segmentation, by End User
9.1 Chapter Overview
9.2 Hospitals
9.2.1 Hospitals Market Trends Analysis (2020-2032)
9.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Blood banks
9.3.1 Blood banks Market Trends Analysis (2020-2032)
9.3.2 Blood Banks Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Diagnostics laboratories
9.4.1 Diagnostics Laboratories Market Trends Analysis (2020-2032)
9.4.2 Diagnostics Laboratories Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Others
9.5.1 Others Market Trends Analysis (2020-2032)
9.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Blood Transfusion Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.4 North America Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.5 North America Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.6.2 USA Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.6.3 USA Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.7.2 Canada Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.7.3 Canada Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.8.2 Mexico Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.8.3 Mexico Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Blood Transfusion Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.6.2 Poland Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.6.3 Poland Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.7.2 Romania Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.7.3 Romania Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Blood Transfusion Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.4 Western Europe Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.5 Western Europe Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.6.2 Germany Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.6.3 Germany Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.7.2 France Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.7.3 France Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.8.2 UK Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.8.3 UK Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.9.2 Italy Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.9.3 Italy Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.10.2 Spain Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.10.3 Spain Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.13.2 Austria Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.13.3 Austria Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Blood Transfusion Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.4 Asia Pacific Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.5 Asia Pacific Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.6.2 China Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.6.3 China Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.7.2 India Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.7.3 India Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.8.2 Japan Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.8.3 Japan Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.9.2 South Korea Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.9.3 South Korea Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.10.2 Vietnam Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.10.3 Vietnam Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.11.2 Singapore Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.11.3 Singapore Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.12.2 Australia Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.12.3 Australia Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Blood Transfusion Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.4 Middle East Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.5 Middle East Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.6.2 UAE Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.6.3 UAE Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Blood Transfusion Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.4 Africa Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.5 Africa Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Blood Transfusion Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.4 Latin America Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.5 Latin America Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.6.2 Brazil Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.6.3 Brazil Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.7.2 Argentina Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.7.3 Argentina Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.8.2 Colombia Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.8.3 Colombia Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Blood Transfusion Diagnostics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Blood Transfusion Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Blood Transfusion Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11. Company Profiles
11.1 Illumina, Inc.
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 Thermo Fisher Scientific Inc.
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 Abbott Laboratories
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 Siemens Healthineers
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 Roche Diagnostics
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 Beckman Coulter, Inc.
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 Becton Dickinson and Company
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Ortho Clinical Diagnostics
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 F. Hoffmann-La Roche AG
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Product
Reagents & kits
Instruments
Others
By Application
Blood grouping
Disease screening
By End-Use
Hospitals
Blood banks
Diagnostics laboratories
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Cardiac Rhythm Management Devices Market was valued at USD 18.51 billion in 2023, projected to reach USD 32.35 billion by 2032, growing at a CAGR of 6.40%.
The Optical Imaging Market size was estimated at USD 1.99 billion in 2023 and is expected to reach USD 5.30 billion by 2032 with a growing CAGR of 11.52% during the forecast period of 2024-2032.
The Osteoarthritis Therapeutics Market was valued at USD 8.65 billion in 2023 and is expected to reach USD 18.09 billion by 2032, growing at a CAGR of 8.52% from 2024 to 2032.
The Military Wearable Medical Device Market Size was valued at USD 7.84 billion in 2023 and is expected to reach USD 64.47 billion by 2032, and grow at a CAGR of 26.40% over the forecast period 2024-2032.
The Pediatric Cardiac Tumor Diagnostic Market was valued at USD 630.15 million in 2023 and is expected to reach USD 1281.29 million by 2032, growing at a CAGR of 8.23% from 2024 to 2032.
The Healthcare Workforce Management Systems Market Size was valued at USD 1.69 billion in 2023, and is expected to reach USD 4.20 billion by 2032, and grow at a CAGR of 10.65% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
